MD1780F1 - Method of treatment of patients with hepatic cirrhosis - Google Patents

Method of treatment of patients with hepatic cirrhosis Download PDF

Info

Publication number
MD1780F1
MD1780F1 MD20010032A MD20010032A MD1780F1 MD 1780 F1 MD1780 F1 MD 1780F1 MD 20010032 A MD20010032 A MD 20010032A MD 20010032 A MD20010032 A MD 20010032A MD 1780 F1 MD1780 F1 MD 1780F1
Authority
MD
Moldova
Prior art keywords
patients
hepatic cirrhosis
treatment
hepatoprotectors
losartan
Prior art date
Application number
MD20010032A
Other languages
Romanian (ro)
Other versions
MD1780G2 (en
Inventor
Vlada-Tatiana Dumbrava
Eugen Tcaciuc
Original Assignee
Univ Nicolae Testemitanu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nicolae Testemitanu filed Critical Univ Nicolae Testemitanu
Priority to MDA20010032A priority Critical patent/MD1780G2/en
Publication of MD1780F1 publication Critical patent/MD1780F1/en
Publication of MD1780G2 publication Critical patent/MD1780G2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to medicine, namely to hepatology. Summary of the invention consists in that concomitantly with the administration of hepatoprotectors and vitamins, the patients with hepatic cirrhosis are additionally administered during 27...35 days losartan for 0,0125...0,025 g one time a day per os.Claims: 1
MDA20010032A 2001-02-02 2001-02-02 Method of treatment of patients with hepatic cirrhosis MD1780G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20010032A MD1780G2 (en) 2001-02-02 2001-02-02 Method of treatment of patients with hepatic cirrhosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20010032A MD1780G2 (en) 2001-02-02 2001-02-02 Method of treatment of patients with hepatic cirrhosis

Publications (2)

Publication Number Publication Date
MD1780F1 true MD1780F1 (en) 2001-11-30
MD1780G2 MD1780G2 (en) 2002-05-31

Family

ID=19739746

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20010032A MD1780G2 (en) 2001-02-02 2001-02-02 Method of treatment of patients with hepatic cirrhosis

Country Status (1)

Country Link
MD (1) MD1780G2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4458C1 (en) * 2014-06-19 2017-08-31 Мария ДАНУ Use of Polybiolin drug in patients with liver cirrhosis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD4458C1 (en) * 2014-06-19 2017-08-31 Мария ДАНУ Use of Polybiolin drug in patients with liver cirrhosis

Also Published As

Publication number Publication date
MD1780G2 (en) 2002-05-31

Similar Documents

Publication Publication Date Title
WO2006008639A8 (en) Combination treatment for non-hematologic malignancies using an anti-igf-1r antibody
IL135335A0 (en) Method for inhibiting or preventing hormone induced adverse effects and novel pharmaceutical compositions comprising carotenoids
MXPA03006217A (en) Spaced drug delivery system.
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
DK0502092T3 (en) Oral preparation for the treatment of inflammatory bowel diseases
NO954996D0 (en) Use of nona and decapeptides for the manufacture of a medicament for the treatment of AIDS
UA88464C2 (en) Method of topical methadone administration providing systemic effect
MXPA05012358A (en) Pharmaceutical combination comprising modafinil and another drug.
NO20080244L (en) Dosage control for prasugrel
MD2549G2 (en) Method of treatment of the chronic viral hepatitis C
MD990258A (en) Method of treatment of the acute viral hepatitis B
PL368686A1 (en) Novel aminobenzoephenones
SG145717A1 (en) Composition for releasing a weak base for an extended period of time
AR048318A1 (en) ORAL MATRIX FORMULATIONS THAT INCLUDE LICARBAZEPINA
MXPA01012936A (en) Pharmaceutical composition containing sibutramine and orlistat.
MD1780G2 (en) Method of treatment of patients with hepatic cirrhosis
NZ514911A (en) Use of N-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients
SE9800905D0 (en) New therapy in glomerulonephritis
MD20060037A (en) Method of treating the acute viral hepatitis C
WO2004073627A3 (en) Novel therapeutic method and compositions for topical administration
AR109456A2 (en) USE OF ET743 FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF A HUMAN PATIENT AFFECTED BY CANCER THROUGH COMBINATION THERAPY
TW200501967A (en) Nemorubicin for use in the preparation of a medicament for liver disease
MD1609F1 (en) Method of the recidivating chronic aphthous stomatitis treatment
AU8353601A (en) Treatment of hepatitis c with thymosin, interferon and ribavirin
MD1469G2 (en) Method of treatment of the burn shock